Treatment Registry

Company

MEDGm

  • 5 programs
  • 3 molecules
  • 5 readings

Read from medgm.org on September 3, 2026. This page records what the company publishes. It is not a review and takes no position on the company.

Go to MEDGm

Enroll with MEDGm

This is a paid link. If you enroll through it, Treatment Registry may earn a commission. It does not change what we record, and it does not change the price you pay.

Terms

PharmacyNot disclosed
MembershipNot disclosed
Consultation feeNot disclosed
StatesNot disclosed

Those the company does not disclose were checked on September 3, 2026.

Terms can differ between this company’s programs; each entry carries its own.

Programs

EntryProviderFormPer month
at its shortest term
Link
TR-0813MEDGmNot recordedEnrollPaid link
TR-0814MEDGmOral tabletNot recordedEnrollPaid link
TR-0815MEDGmNot recordedEnrollPaid link
TR-0816MEDGmInjection, penNot recordedEnrollPaid link
TR-0817MEDGmNot recordedEnrollPaid link

Notes

Recorded against this company rather than one program.

September 3, 2026

  1. 1. MEDGm's catalog prints “STARTING AT $179” against its GLP-1 injection program and attaches no billing period to it. The words month, monthly and per month appear nowhere beside a price on that page, and every button next to a figure opens the intake questionnaire rather than a plan. Its refund policy does describe how the program is billed — “paid for the first term of the Subscription Service, whether monthly or a multi-month bundle (3, 6, or 12-month bundle)” — but attaches that to no figure, so it settles the structure and leaves the price without a period.
  2. 2. Behind the intake questionnaire, MEDGm shows a plan ladder its public catalog does not: $239 a month on twelve months, $289 on six, $319 on three, and a month-to-month rate of $369 with $249 struck through beside it under a twenty-minute countdown. That screen is fitted to the answers given, carries a timer, and quotes figures the catalog page contradicts, so it describes a single visit rather than a published price.
Show 5 more notesHide 5 more notes
  1. 3. MEDGm's catalog prints “STARTING AT $249” against its GLP-1 tablet program and attaches no billing period to it. The words month, monthly and per month appear nowhere beside a price on that page, and every button next to a figure opens the intake questionnaire rather than a plan. Its refund policy does describe how the program is billed — “paid for the first term of the Subscription Service, whether monthly or a multi-month bundle (3, 6, or 12-month bundle)” — but attaches that to no figure, so it settles the structure and leaves the price without a period.
  2. 4. MEDGm sells Zepbound® as “$99 MEMBERSHIP + COST”: the membership carries a price and the medication is billed on top of it. The $99 buys access to the program, not the drug, so a reader setting it beside an all-in monthly program is not comparing like with like. MEDGm attaches no period to the membership figure either.
  3. 5. MEDGm sells Ozempic® as “$171 MEMBERSHIP + COST”: the membership carries a price and the medication is billed on top of it. The $171 buys access to the program, not the drug, so a reader setting it beside an all-in monthly program is not comparing like with like. MEDGm attaches no period to the membership figure either.
  4. 6. MEDGm sells Wegovy® as “$99 MEMBERSHIP + COST”: the membership carries a price and the medication is billed on top of it. The $99 buys access to the program, not the drug, so a reader setting it beside an all-in monthly program is not comparing like with like. MEDGm attaches no period to the membership figure either.
  5. 7. MEDGm lists this as “Wegovy® Pill or Pen” and does not say which of the two it supplies. The pill and the pen are different products at different doses.

Before you act

Cite this

Treatment Registry. (2026). MEDGm: recorded programs and prices. Last verified September 3, 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/medgm